Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Fate Therapeutics, Inc. (F6T.F)

1.1715
+0.0245
+(2.14%)
As of 8:25:37 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
13,631
13,631
63,533
96,300
55,846
Operating Expense
209,170
209,170
254,044
404,686
272,840
Operating Income
-195,539
-195,539
-190,511
-308,386
-216,994
Net Non Operating Interest Income Expense
17,288
17,288
17,186
5,842
1,309
Other Income Expense
-8,011
-8,011
12,397
20,823
3,534
Pretax Income
-186,262
-186,262
-160,928
-281,721
-212,151
Net Income Common Stockholders
-186,262
-186,262
-160,928
-281,721
-212,151
Diluted NI Available to Com Stockholders
-186,262
-186,262
-160,928
-281,721
-212,151
Basic EPS
-1.64
--
-1.64
-2.91
-2.24
Diluted EPS
-1.64
--
-1.64
-2.91
-2.24
Basic Average Shares
113,685.1770
--
98,411.1620
96,826.0580
94,747.3110
Diluted Average Shares
113,685.1770
--
98,411.1620
96,826.0580
94,747.3110
Total Operating Income as Reported
-210,276
-210,276
-190,511
-308,386
-216,994
Total Expenses
209,170
209,170
254,044
404,686
272,840
Net Income from Continuing & Discontinued Operation
-186,262
-186,262
-160,928
-281,721
-212,151
Normalized Income
-172,344
-172,344
-163,443
-302,028
-215,685
Interest Income
17,288
17,288
17,186
5,842
1,309
Net Interest Income
17,288
17,288
17,186
5,842
1,309
EBIT
-195,539
-195,539
-190,511
-308,386
-216,994
EBITDA
-176,577
-176,577
-172,229
-294,628
-211,144
Reconciled Depreciation
18,962
18,962
18,282
13,758
5,850
Net Income from Continuing Operation Net Minority Interest
-186,262
-186,262
-160,928
-281,721
-212,151
Total Unusual Items Excluding Goodwill
-13,918
-13,918
2,515
20,307
3,534
Total Unusual Items
-13,918
-13,918
2,515
20,307
3,534
Normalized EBITDA
-162,659
-162,659
-174,744
-314,935
-214,678
12/31/2021 - 10/3/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVU0.F Adverum Biotechnologies, Inc.
2.5800
+4.88%
 
HXBM Helix BioMedix, Inc.
7.18
0.00%
 
1JK.F Apellis Pharmaceuticals, Inc.
14.78
-6.43%
 
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+2.68%
 
38I.F Intellia Therapeutics, Inc.
6.89
+2.83%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0075
+2.74%
 
ANTX AN2 Therapeutics, Inc.
1.2900
+1.57%
 
TYRA Tyra Biosciences, Inc.
10.09
+0.70%
 
SION Sionna Therapeutics, Inc.
12.60
-3.74%
 
KYTX Kyverna Therapeutics, Inc.
2.1400
+0.47%